BL
BioLineRx Ltd.
BLRX · NASDAQ
$2.48 -1.59% (-$0.04)
1M -17.00%
Market Cap $10.8M
P/E Ratio -
Div. Yield -
ROE 47.11%
Bulios Fair Price
$3.5
41.1% upside
Trenutna cena
$2.48
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BLRX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
54 /100
Fair P/S 7.74x
P/B 0.79x
P/E N/A
Growth
0 /100
Declining Book val. growth 29.00%
EPS growth N/A
Rev. growth N/A
Profitability
20 /100
Weak Gross margin 69.82%
Net margin 574.26%
FCF margin 779.65%
Quality
0 /100
Poor ROIC 49.89%
ROE 47.11%
Asset turnover 0.04x
Debt
47 /100
Moderate Debt/Equity 0.58x
Current ratio 1.20x
Int. coverage -8.22x
Stability
37 /100
Moderate Beta 0.70x
EPS volatility 121.11%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BLRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Philip A. Serlin
Employees
22
Headquarters
Hevel Modi'in
Prihajajoči dogodki
23 NOV.
Earnings
Upcoming earnings report